Roche Holding AG (RHHBF) Financials
RHHBF Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 120.7 billion | 75.6 billion |
| Dec. 31, 2025 | 127.0 billion | 79.2 billion |
| June 30, 2025 | 119.5 billion | 77.8 billion |
| Dec. 31, 2024 | 112.6 billion | 72.6 billion |
RHHBF Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 6.9 billion | ? |
| Dec. 31, 2025 | 11.6 billion | ? |
| June 30, 2025 | 3.4 billion | 247.2 million |
| Dec. 31, 2024 | 9.8 billion | 495.4 million |
RHHBF Net Income
| Date | Net Income |
|---|---|
| June 30, 2026 | 8.4 billion |
| Dec. 31, 2025 | 6.9 billion |
| June 30, 2025 | 4.7 billion |
| Dec. 31, 2024 | 3.2 billion |
RHHBF Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 12.0 billion | 31.0 billion | - |
| Dec. 31, 2025 | 19.5 billion | 34.6 billion | 2.0 billion |
| June 30, 2025 | 15.2 billion | 33.4 billion | 2.0 billion |
| Dec. 31, 2024 | 19.1 billion | 34.0 billion | 1.9 billion |
RHHBF Shares Outstanding
RHHBF Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 1.9 billion | 8.9 billion | 8.4 billion | - |
| Dec. 31, 2025 | 2.6 billion | 8.4 billion | 10.3 billion | - |
| June 30, 2025 | 1.1 billion | 4.2 billion | 4.2 billion | - |
| Dec. 31, 2024 | 3.6 billion | 8.8 billion | 8.0 billion | - |
RHHBF Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 37.3 billion | 9.8 billion |
| Dec. 31, 2025 | 38.6 billion | 10.9 billion |
| June 30, 2025 | 20.1 billion | 4.9 billion |
| Dec. 31, 2024 | 35.0 billion | 9.7 billion |
RHHBF
Price: $458.47
Dividend Yield: 2.90%
Forward Dividend Yield: 5.71%
Payout Ratio: 70.22%
Dividend Per Share: 24.82 USD
Earnings Per Share: 19.81 USD
P/E Ratio: 23.47
Exchange: OQX
Sector: Healthcare
Industry: Drug Manufacturers - General
Country: Switzerland
Market Capitalization: 340.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25
DGR3: 30.00%
DGR5: 23.68%
DGR10: 12.92%
DGR20: 12.90%